S. Brunell

发表

Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis.

W. Sheu, S. Brunell, E. Blasé, 2016, Diabetes research and clinical practice.

Exenatide Twice Daily: Analysis of Effectiveness and Safety Data Stratified by Age, Sex, Race, Duration of Diabetes, and Body Mass Index

S. Brunell, R. Pencek, A. Blickensderfer, 2012, Postgraduate medicine.

Exenatide Once Weekly Versus Daily Basal Insulin as Add-on Treatment to Metformin With or Without a Sulfonylurea: A Retrospective Pooled Analysis in Patients With Poor Glycemic Control

S. Brunell, E. Blasé, Yan Li, 2013, Postgraduate medicine.

Factors influencing elevated ethanol consumption in adolescent relative to adult rats.

L. Spear, S. Brunell, Tamara L. Doremus, 2005, Alcoholism, clinical and experimental research.

Effects of pramlintide in patients with type 2 diabetes mellitus: an analysis using daily insulin dose tertiles.

S. Brunell, K. Herrmann, K. Shan, 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Exenatide once weekly for the treatment of type 2 diabetes: effectiveness and tolerability in patient subpopulations

S. Brunell, R. Pencek, A. Blickensderfer, 2012, International journal of clinical practice.

Optimizing the Clinical Use of the GLP-1 Receptor Agonist Exenatide Once Weekly

S. Brunell, M. Deyoung, E. Bezarro, 2013, Diabetes Spectrum.

Determination of endocannabinoid receptor antagonist SR141716 (rimonabant) in plasma by liquid chromatograph tandem mass spectrometry.

Yan Xu, L. Spear, S. Brunell, 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Effects of acute ethanol or amphetamine administration on the acoustic startle response and prepulse inhibition in adolescent and adult rats

L. Spear, S. Brunell, 2006, Psychopharmacology.

Effect of stress on the voluntary intake of a sweetened ethanol solution in pair-housed adolescent and adult rats.

L. Spear, S. Brunell, 2005, Alcoholism, clinical and experimental research.

Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials

S. Brunell, D. Maggs, Yan Li, 2016, Advances in Therapy.

Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US

J. Best, S. Brunell, Y. Samyshkin, 2012, Journal of medical economics.

Anxiogenic effects during withdrawal from acute ethanol in adolescent and adult rats

L. Spear, S. Brunell, E. Varlinskaya, 2003, Pharmacology Biochemistry and Behavior.

Use of concomitant glucose-lowering therapies and associated treatment results observed in clinical trials of twice-daily exenatide.

B. Hoogwerf, S. Brunell, R. Pencek, 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Determination of endocannabinoid receptor antagonist SR141716 (rimonabant) in plasma by liquid chromatograph tandem mass spectrometry.

Yan Xu, L. Spear, S. Brunell, 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Exenatide Once Weekly for the Treatment of Type 2 Diabetes Mellitus: Clinical Results in Subgroups of Patients Using Different Concomitant Medications

B. Hoogwerf, S. Brunell, R. Pencek, 2012, Postgraduate medicine.

Exenatide Once Weekly Versus Daily Basal Insulin as Add-on Treatment to Metformin With or Without a Sulfonylurea: A Retrospective Pooled Analysis in Patients With Poor Glycemic Control

S. Brunell, E. Blasé, Yan Li, 2013, Postgraduate medicine.